Asmau Nasiru Hamza

Prof. Asmau Nasiru Hamza

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in Journal of Current Biomedical Research
Verified
Journal Article
Closed access
PDF file
AOAmina Busola Olorukooba
Amina Busola Olorukooba
ASAishatu Shehu
Aishatu Shehu
FKFerhat Khan
Ferhat Khan
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
AMAisha Oiza Musa
Aisha Oiza Musa
MSMunir Ari Sani
Munir Ari Sani
Senna italica Mill. belonging to the family Fabaceae has been used traditionally to treat various ailments diseases including skin diseases, fever, jaundice, stomachache, burns and inflammation. The aim of the present study was to evaluate the phytochemical profile and the anti-inflammatory activity of the methanol leaf extract of the plant. Preliminary phytochemical screening and oral acute toxicity studies were carried out using standard protocols. Anti-inflammatory activity was investigated in Wistar rats using cotton pellet-induced granuloma model at doses of 250, 500 and 1000 mg/kg. Hematological and biochemical parameters were also evaluated. Phytochemical screening revealed the presence of tannins, saponins, carbohydrate, alkaloids, flavonoids, and steroids. The oral median lethal dose was estimated to be greater than 5000 mg/kg. The extract reduced wet granuloma weight with percentage inhibition of 5.9%, 52.9% and 47.1 % at doses of 250, 500 and 1000 mg/kg respectively compared to the negative control. At same doses, the extract showed 14.3%, 17.1% and 28.6% inhibition in weight of dry cotton pellet. A significant (p<0.05) reduction was observed in platelets, platelet lymphocyte ratio, creatinine, aspartate aminotransferase and alkaline phosphatase levels.The result from this study suggests that the methanol leaf extract of Senna italica has anti-inflammatory activity supporting the traditional use of the plant in the treatment of inflammation and inflammatory related diseases.

29 April 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Amina Jega YusufAmina Jega Yusuf
Amina Jega Yusuf
MAMusa Ismail Abdullahi
Musa Ismail Abdullahi
AMAliyu Muhammad Musa
Aliyu Muhammad Musa
HAHassan Abubakar
Hassan Abubakar
AAAbubakar Muhammad Amali
Abubakar Muhammad Amali
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
The novel coronavirus disease-2019 (COVID-19) that emerged in China, is a highly transmittable and pathogenic viral infection caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2); the disease has been declared by the World Health Organization as a Public Health Emergency of International Concern. The unavailability of approved therapeutic agents or vaccines is of great concern. This study performed molecular docking and absorption, distribution, metabolism, excretion and toxicity (ADMET) analysis of some compounds isolated from Neocarya macrophylla (Sabine) Prance ex F. White (Chrysobalanaceae) against three targets of SARS-CoV-2 proteins (3C-like protease, spike protein, and papain-like protease). Phytoconstituents isolated from N. macrophylla were screened against key targets of SARS-CoV-2 using Auto Dock Vina, while the ADMET analysis was performed using swiss ADME and pkCSM ADMET descriptors algorithm protocols. The in silico computational studies revealed that the compounds (catechin, catechin-3-rhamnoside, quercetin, and epicatechin) isolated from N. macrophylla can effectively bind with high affinity and lower energy values to the three target proteins of SARS-CoV-2. ADMET analysis was used to predict important pharmacokinetic properties of the compounds, such as aqueous solubility, blood-brain barrier, plasma protein binding, CYP2D6 binding, intestinal absorption, and hepatotoxicity. The findings of this study have shown that N. macrophylla contains potential leads for SARS-CoV-2 inhibition and thus, should be studied further for development as therapeutic agents against COVID-19.

22 April 2026 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
EOEnayi Onaji
Enayi Onaji
GAGrace Adaji
Grace Adaji
CAChukwunenye Christopher Azubuike
Chukwunenye Christopher Azubuike
MAMukhtar Sani Adam
Mukhtar Sani Adam
LALucky Apeh
Lucky Apeh
EOEdwin Ameh Ojila
Edwin Ameh Ojila
Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the absence of conventional hormonal receptors, leading to intrinsic resistance to standard therapies and poor clinical outcomes. Topoisomerase I (TOP1) and Topoisomerase II alpha (TOP2A), essential enzymes for DNA replication and transcription, have emerged as promising co-targets to overcome this therapeutic resistance. This study employed an integrated in-silico pipeline to discover novel dual-targeting inhibitors against both TOP1 and TOP2A. A structure-based pharmacophore model (AAHRR_7) was developed and rigorously validated, demonstrating high predictive power. Subsequent virtual screening of a ZINC in-trial compound library identified 475 hits, which were advanced to molecular docking against the crystal structures of TOP1 (PDB: 1T8I) and TOP2A (PDB: 4FM9). This process yielded 15 top-ranked compounds with significantly superior predicted binding affinities compared to reference inhibitors. MM/GBSA refinement and systematic ADMET profiling further prioritized two in-silico candidate molecules ZINC13740825 and ZINC00586527 which exhibited robust binding free energies and favorable drug-like properties with low predicted toxicity. Quantitative structure-activity relationship (QSAR) models and Molecular Dynamics Simulation studies confirmed their potent predicted inhibitory activity and complex stability against both targets. These findings highlight the potential of these identified compounds as promising dual TOP1/TOP2A inhibitors for TNBC therapy, offering a strategic avenue to combat resistance mechanisms. Further experimental validation is warranted to translate these computational insights into therapeutic candidates.

13 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
BIBeatrice Nkiruka Iwuala
Beatrice Nkiruka Iwuala
MMMark Madumelu
Mark Madumelu
AAAbubakar Babando Aliyu
Abubakar Babando Aliyu
RARacheal Gbekele-Oluwa Ayo
Racheal Gbekele-Oluwa Ayo
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
JHJames Habila
James Habila
The development of novel antimalarial agents with defined mechanisms of action is an urgent priority in the face of escalating Plasmodium falciparum drug resistance. Building upon previously validated machine learning classification models and a curated chalcone dataset, this study reports the construction of an Extremely Randomized Trees (Extra Trees) quantitative structure-activity relationship (QSAR) regression model optimized for pIC50 prediction, followed by rational structure-based design, in silico activity prediction, pharmacokinetic profiling, and molecular docking evaluation of twelve novel chalcone derivatives against PfDHODH (PDB: 4CQ8). The optimized QSAR model achieved R2_train = 0.95, R2_test = 0.85, and R2_cv = 0.89, with MSE values of 0.078 and 0.177 for training and test sets respectively, passing Y-randomization validation (cR2p = 0.666). Lead compound MB189 (pIC50 = 7.588, residual = 0.167) was selected for scaffold-based optimization. QSAR-predicted pIC50 values ranged from 7.540 to 7.641 (mean 7.594 ± 0.028), with 75% of compounds exceeding MB189 activity; all fell within the model applicability domain (leverage 0.129–0.620). ADMET profiling confirmed high predicted intestinal absorption (82–91%), uniform CYP3A4 substrate activity without CYP2D6 involvement for most analogues, and negative AMES mutagenicity. Molecular docking against PfDHODH yielded binding affinities of -9.1 to -10.8 kcal/mol (mean -9.77 ± 0.45 kcal/mol), surpassing MB189 (-9.3 kcal/mol) for ten of twelve compounds. BB12 exhibited the strongest predicted binding affinity (-10.8 kcal/mol), uniquely interacting with the FMN cofactor and forming three hydrogen bonds with His185, Tyr528, and Cys184. BB6 formed dual hydrogen bonds with the catalytic Arg265 at shorter distances (1.94–2.54 Å) than the reference inhibitor Genz-669178 (2.92 Å), indicating superior anchoring. BB2 established the richest hydrogen bond profile (five bonds; Ser160, Tyr168, Leu197), while BB4 achieved full Lipinski compliance without predicted activity loss. Collectively, BB12, BB6, BB2, and BB4 are prioritized as candidates for experimental synthesis and biological evaluation, with BB2 and BB4 offering the optimal balance of predicted potency and drug-likeness among the series.

6 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
BIBeatrice Nkiruka Iwuala
Beatrice Nkiruka Iwuala
MMMark Madumelu
Mark Madumelu
AAAbubakar Babando Aliyu
Abubakar Babando Aliyu
RARacheal Gbekele-Oluwa Ayo
Racheal Gbekele-Oluwa Ayo
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
JHJames Habila
James Habila
The rapid emergence of drug-resistant Plasmodium falciparum necessitates efficient computational tools to prioritize novel antimalarial scaffolds. This study establishes a robust machine learning framework for predicting the bioactivity of chalcone derivatives, specifically addressing the challenge of dataset imbalance in quantitative structure-activity relationship (QSAR) modeling. 1,440 model combinations were systematically evaluated, comprising twelve classification algorithms, twelve molecular fingerprint types and three sampling strategies, on a curated dataset of 251 chalcones. The results demonstrate that the ExtraTreesClassifier, combined with KlekotaRothCount fingerprints and an oversampling strategy, achieves superior predictive performance (MCC = 1.0; Accuracy = 100% on independent test sets), significantly outperforming standard approaches. Critical feature importance analysis revealed that nitrogen-containing heterocycles and specific aromatic configurations are the primary structural drivers of antimalarial potency. Unlike previous benchmarks, this study proves that oversampling is essential for stabilizing model performance in small, imbalanced chemical datasets. These findings provide a validated, high-precision computational tool for the rational design of next-generation antimalarial agents.

29 March 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
SBSodeeq Adewale Babalola
Sodeeq Adewale Babalola
NINosakhare Igie
Nosakhare Igie
AIAbullah Idris
Abullah Idris
YSYeken Sanni
Yeken Sanni
AHAsmau Nasiru Hamza
Asmau Nasiru Hamza
LBLateef Bakare
Lateef Bakare
We conducted a comparative study on the development of two synthetic methods. The solvent-free synthesis is a green chemistry method developed in a bid to ameliorate environmental adverse effects of the conventional solvent-based synthesis. The synthesis of novel dichloro and polymethoxy p-nitrophenylhydrazones through solvent free technique gave moderate to high yields which were however lower than those of the solvent-based method. The established solvent-free approach has several benefits, including universality and simplicity of the approach, catalyst-free conditions, non-use of an organic solvent, quick reaction time, fast and efficient workup, and un-solvated pure products in moderate to high yields.
1